Benitec Biopharma Inc. - ADR

Name: Benitec Biopharma Inc. - ADR Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Benitec Biopharma Inc. - ADR

Stock Card

$12.47

$-0.20 (-1.58%)

As on 28-Aug-2026 16:00EDT

Market cap

$428 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

P/B Ratio

2.4

Div. Yield

0 %

Benitec Biopharma - ADR Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 11.71 High: 12.76

52 Week Range

Low: 9.85 High: 16.76

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.3 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

850.9
Debt to Equity

0
Book Value

$5.3
EPS

$-1.2
Face value

--
Shares outstanding

34,354,334

10 Years Aggregate

CFO

$-105.93 Mln

EBITDA

$-98.22 Mln

Net Profit

$-108.43 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Benitec Biopharma - ADR	-7.4	7.7	7.5	-3.0	72.0	-28.8	-60.6
BSE Sensex	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Benitec Biopharma - ADR	6.7	286.7	11.8	-93.5	-12.7	-60.8	-66.0
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Benitec Biopharma - ADR	12.5	428.4	0.6	-48.9	-9,701.1	-35.3	--	2.4
Arrowhead Pharmaceuticals (ARWR)	84.9	11,993.9	669.5	-320.0	-0.8	-71.1	--	26.9
Ascendis Pharma A/S - ADR	247.9	16,261.1	1,054.4	755.9	5.7	--	19	9.8
Cytokinetics Inc (CYTK)	72.1	10,022.2	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	54.5	13,491.7	2,435.9	860.6	31.0	43	17.4	7.4
Halozyme Therapeutics (HALO)	105.4	11,957.0	1,663.7	413.6	36.3	430	30.9	84.5
Krystal Biotech (KRYS)	351.5	10,402.8	440.5	241.5	33.4	18.7	44.1	7.8
Madrigal Pharmaceuticals (MDGL)	533.8	12,332.1	1,283.9	-325.1	-19.0	-57.7	--	24.0
Medpace Holdings (MEDP)	600.7	16,765.1	2,782.3	491.5	21.1	110.1	35.2	39.3
Praxis Precision MedicinesÂ Inc (PRAX)	344.8	9,625.4	0.0	-339.1	--	-30.6	--	7.6

Shareholding Pattern

View Details

About Benitec Biopharma - ADR

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines... that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California. Read more

Executive Chairman & CEO

Dr. Jerel A. Banks M.D., Ph.D.
Executive Chairman & CEO

Dr. Jerel A. Banks M.D., Ph.D.
Headquarters

Hayward, CA
Website

https://benitec.com

FAQs for Benitec Biopharma - ADR

What is the current share price of Benitec Biopharma Inc - ADR Today?

The share price of Benitec Biopharma Inc - ADR is $12.47 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Benitec Biopharma Inc - ADR has given a return of 72.02% in the last 3 years.

What is the current PB & PE ratio of Benitec Biopharma Inc - ADR?

Since, TTM earnings of Benitec Biopharma Inc - ADR is negative, P/E ratio is not available.
The P/B ratio of Benitec Biopharma Inc - ADR is 2.38 times as on 28-Aug-2026, a 56 discount to its peers’ median range of 5.35 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-11.17	4.35
2024	-3.24	1.49
2023	-0.08	7.77
2022	-0.12	0.77
2021	-0.51	0.35

What is the 52 Week High and Low of Benitec Biopharma Inc - ADR?

The 52-week high and low of Benitec Biopharma Inc - ADR are Rs 16.76 and Rs 9.85 as of 30-Aug-2026.

What is the market cap of Benitec Biopharma Inc - ADR?

Benitec Biopharma Inc - ADR has a market capitalisation of $ 428 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Benitec Biopharma Inc - ADR?

Before investing in Benitec Biopharma Inc - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.